Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study-Reference-Cited by-同舟云学术

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

Published:2021-02 Issue:2 Volume:8 Page:e135-e148
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Pleyer Lisa,Leisch Michael,Kourakli Alexandra,Padron Eric,Maciejewski Jaroslaw Pawel,Xicoy Cirici Blanca,Kaivers Jennifer,Ungerstedt Johanna,Heibl Sonja,Patiou Peristera,Hunter Anthony Michael,Mora Elvira,Geissler Klaus,Dimou Maria,Jimenez Lorenzo Maria-José,Melchardt Thomas,Egle Alexander,Viniou Athina-Nora,Patel Bhumika Jayantibhai,Arnan Montserrat,Valent Peter,Roubakis Christoforos,Bernal del Castillo Teresa,Galanopoulos Athanasios,Calabuig Muñoz Marisa,Bonadies Nicolas,Medina de Almeida Antonio,Cermak Jaroslav,Jerez Andrés,Montoro Maria Julia,Cortés Albert,Avendaño Pita Alejandro,Lopez Andrade Bernardo,Hellstroem-Lindberg Eva,Germing Ulrich,Sekeres Mikkael Aaron,List Alan Francis,Symeonidis Argiris,Sanz Guillermo Francisco,Larcher-Senn Julian,Greil Richard

Publisher

Elsevier BV

Subject

Hematology

Reference34 articles.

1. Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: a comparison between Swiss and American population-based cancer registries;Benzarti;Cancer Epidemiol,2019

2. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia;Bennett;Br J Haematol,1994

3. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study;Fenaux;Lancet Oncol,2009

4. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study;Kantarjian;Cancer,2006

5. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B;Silverman;J Clin Oncol,2002

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia;Cell Reports Medicine;2024-06

2. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

3. Ungewöhnliche Progression einer Polycythaemia vera;Die Innere Medizin;2024-05-22

4. Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine—A prospective cohort study by the AGMT;American Journal of Hematology;2023-08-07

5. Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia;Current Treatment Options in Oncology;2023-06-10